July 19, 2018 Price forecast | 2 weeks: -1.29% | 1 month: -0.99% | 3 months: 2.20%

TRXC stock forecast

Our latest prediction for TransEnterix, Inc.'s stock price was made on the July 19, 2018 when the stock price was at 5.03$.

In the short term (2weeks), TRXC's stock price should underperform the market by -1.29%. During that period the price should oscillate between -10.86% and +13.66%.

In the medium term (3months), TRXC's stock price should outperform the market by 2.20%. During that period the price should oscillate between -22.93% and +34.18%.

Create a solid portfolio with TRXC

Add TRXC to your portfolio and optimize it!

About TransEnterix, Inc.

TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

At the moment the company generates 20M USD in revenues.

On its last earning announcement, the company reported a loss of -0.73$ per share.

The book value per share is 0.79$

TransEnterix, Inc. website

Three months stock forecastJuly 19, 2018


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
20M 29.70% -63M -313.00% -131M -0.73 - - 201M 0.79 -38M -1M -38M